Characterization of inflammatory responses during intranasal colonization with Streptococcus pneumoniae

Journal of Visualized Experiments

Volumn , Issue 83, 2014, Pages

  Puchta, Alicja ^a   Verschoor, Chris P ^a   Thurn, Tanja ^a   Bowdish, Dawn M E ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Effector cells; Flow cytometry; Immunology; Intranasal colonization; Issue 83; Murine; Nasal lavage; Nasopharynx; Neutrophils; Quantitative PCR; Recruited macrophages; RNA; Streptococcus pneumoniae; T cells

Indexed keywords

ANIMAL; ARTICLE; C57BL MOUSE; DISEASE MODEL; FEMALE; GROWTH, DEVELOPMENT AND AGING; INFLAMMATION; INTRANASAL DRUG ADMINISTRATION; MICROBIOLOGY; MOUSE; NASOPHARYNX; PATHOLOGY; PNEUMOCOCCAL INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADMINISTRATION, INTRANASAL; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; MICE; MICE, INBRED C57BL; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 84907638348     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/50490     Document Type: Article

References (39)

1. Bogaert, D., de Groot, R., et al. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4, 144-154 (2004).
2. Kadioglu, A., Weiser, J.N., et al. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol.6(4), 288-301 (2008).
3. McCool, T.L., Cate, T.R., et al. The immune response to pneumococcal proteins during experimental human carriage. J. Exp. Med. 195, 359-365 (2002).
4. Nelson, A., Roche, A.M., et al. Capsule enhances pneumococcal colonisation by limiting mucus-mediated clearance. Infect. Immun. 75, 83-90 (2007).
5. van Rossum, A., Lysenko, E., et al. Host and bacterial factors contributing to the clearance of colonisation by Streptococcus pneumoniae in a murine model. Infect. Immun. 73, 7718-7726 (2005).
6. Barocchi M.A., Ries, J., et al. A pneumococcal pilus influences virulence and host inflammatory responses. Proc. Natl. Acad. Sci. U.S.A. 103, 2857-2862 (2006).
7. Malley, R., Henneke, P., et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. U.S.A. 100, 1966-1971 (2003).
8. McCool, T.L. & Weiser, J.N. Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect. Immun. 72, 5807-5813 (2004).
9. Gingles, N.A., et al. Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains. Infect. Immun. 69(1), 426-434 (2001).
10. Jeong, D., Jeong, E., et al. Difference in resistance to Streptococcus pneumoniae infection in mice. Lab Anim. Res. 27, 91-98 (2011).
11. Wu, H.Y., Virolainen, A., et al. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb. Pathog. 23, 127-137 (1997).
12. Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Southam, D.S., Dolovich, M., et. al. Lung Physiol. 282, L833-L839 (2002).
13. Miller, M.A., Stabenow J.M., et al. Visualization of Murine Intranasal Dosing Efficiency Using Luminescent Francisella tularensis: Effect of Instillation Volume and Form of Anesthesia. PLoS ONE. 7(2), e31359, doi:10.1371/journal.pone.0031359 (2012).
14. Briles, D.E. & Novak, L. Nasal Colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci. Infect. Immun.73(10), 6945-6951 (2005).
15. Wu, H.-Y., Virolainen, A., et al. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb. Pathog. 23, 127-137 (1997).
16. Mo Y., Wan R., et al. Application of reverse transcription-PCR and real-time PCR in nanotoxicity research. Methods Mol. Biol. 926, 99-112 (2012).
17. Kuper, C.F., Koornstra, P.J., et al. The role of nasopharyngeal lymphoid tissue. Trends Immunol. 13, 219-224 (1992).
18. Zhang, Q., Leong, S.C., et al. Characterisation of regulatory T cells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization. PLoS Pathog. 7, e1002175 (2011).
19. Briles, D.E., Novak, L., et al. Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci. Infect. Immun. 73, 6945-6951 (2005).
20. Weinberger, D.M., Trzcinski, K., et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog. 5, e1000476 (2009).
21. Hausdorff, W.P., Bryant, J., et al. Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I. Clin. Infect. Dis. 30, 100-121 (2000).
22. Hausdorff, W.P., Feikin, D.R., et al. Epidemiological differences among pneumococcal serotypes. Lancet Infect. Dis. 5, 83-93 (2005).
23. Brueggemann, A., Griffiths, D., et al. Clonal Relationships between Invasive and Carriage Streptococcus pneumoniae and Serotype and Clone Specific Differences in Invasive Disease Potential. J. Infect. Dis. 187, 1424-1432 (2003).
24. Mohler, J., Azoulay-Dupis, E., et al. Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia. Intensive Care Med. 29, 808-816 (2003).
25. Wu, H.Y., Virolainen, A., Mathews, B., King, J., Russell, M.W., et al. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb. Pathog. 23, 127-137 (1997).
26. Zhang, Z., Clarke, T.B., et al. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J. Clin. Invest. 119, 1899-1909 (2009).
27. Parker, D., Martin, F.J., et al. Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. MBio. 2, e00016-11 (2011).
28. Haya, D.L. & Camilli, A. Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol. Microbiol. 45, 1389-1406 (2002).
29. Nakamura, S., Favis, K.M., et al. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniaecolonization in mice. J. Clin. Invest. 121, 3657-3665 (2011).
30. Kim, J.O. & Weiser, J.N. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence ofStreptococcus pneumoniae. J. Infect. Dis. 177, 368-377 (1998).
31. Roche, A.M., King, S.J., et al. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect. Immun. 75, 2469-2475 (2007).
32. Cohen, J.M., Khandavalli, S., Camberlein, E., Hyams, C., Baxendale, H. E., & Brown, J. S. Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-Cell responses to nasopharyngeal colonisation. PLoS One. 6(10), e25558, doi: 10.1371/journal.pone.0025558 (2011).
33. Cohen, J.M., Khandavalli, S., Camberlein, E., Hyams, C., Baxendale, H. E., & Brown, J. S. Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-Cell responses to nasopharyngeal colonisation. PLoS One. 6(10), e25558, doi: 10.1371/journal.pone.0025558 (2011).
34. Richards, L., Ferreira, D.M., Miyaji, E.N., Andrew, P.W., & Kadioglu, A. The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. Immunobiology. 215, 251-263 (2010).
35. Lanie, J.A., Ng, W.L., et al. Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6. J. Bacteriol. 189, 38-51 (2007).
36. Robertson, G. T., Ng, W. L., Foley, J., Gilmour, R., & Winkler, M. E. Global transcriptional analysis of clpP mutations of type 2 Streptococcus pneumoniaeand their effects on physiology and virulence. J. Bacteriol. 184, 3508-3520 (2002).
37. Orihuela, C.J., Gao, G., et al. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J. Infect. Dis. 190, 1661-1669 (2004).
38. Orihuela, C.J., Gao, G., et al. Organ-specific models of Streptococcus pneumoniae disease. Scand. J. Infect. D. 35, 647-652 (2003).
39. Swirski, F.K., Nahrendorf, M., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 325, 612-616 (2009).